BGIN BLOCKCHAIN LIMITED announced its participation in the 15th Annual ROTH Technology Conference on November 17-18, 2026, in New York City. The company's management will hold one-on-one and small group meetings with institutional investors, highlighting its focus on proprietary cryptocurrency mining technologies and hardware manufacturing. This engagement aims to strengthen investor relations and showcase BGIN's strategic direction in the crypto mining sector. Interested investors can schedule meetings through ROTH Capital Partners or BGIN's investor relations team.
BGIN BLOCKCHAIN LIMITED's participation in the 15th Annual ROTH Technology Conference is noted alongside Pluang's market data snapshot as of Nov 10, 2026 19:16 WIB. On that day, out of 150 US stocks tradable on Pluang, 82 rose and 60 fell. Notable movers include Li Auto Inc (LI) at USD 12.78 with a 1-day change of +3.53% and a typical hold time of 104 days, Newmont Corporation (NEM) at USD 122.31 down 2.28%, and Kinross Gold Corporation (KGC) at USD 22.34 down 2.23%, with strong buy interest at 97% on Pluang orders for KGC.
project44 has partnered with Snowflake to enhance supply chain decision-making through Mo, an AI-powered supply chain analyst. Mo uses project44's extensive logistics data and Snowflake Cortex AI to provide accurate, consistent answers to complex sup...
H&R Block has launched the Emerald Advance Loan, a fixed-rate short-term loan up to $1,750 with a 35.90% APR, designed to help families cover year-end expenses without monthly payments. Borrowers repay the loan in full by March 31, 2027, with no impa...
Duke Robotics has entered a strategic collaboration with Greek security firm CRONOS to commercialize its Insulator Cleaning Drone (IC Drone) technology in Greece. This partnership leverages CRONOS's strong presence in Greece's critical infrastructure...
Alm. Brand A/S repurchased 1,369,397 shares between November 3 and 9, 2026, at an average price of DKK 17.46 per share. This is part of their announced buy-back program totaling up to DKK 593 million, aiming to reduce the number of outstanding shares...
Novartis has secured first place in the 2026 Access to Medicine Index, maintaining its lead since 2024 by excelling across all assessed technical areas, including governance, R&D, and product delivery. The company scored 3.86 out of 5 overall, with a...
